{"ticker": {"uuid": "b4ba362c-bd91-4371-8202-3ade820dab5d", "symbol": "BDX", "name": "BCAL Diagnostics Limited", "exchange": "ASX", "country": "AU", "sector": "Healthcare", "industry": "Diagnostics & Research"}, "articles": [{"title": "BCAL Diagnostics Issues 1 Million Unquoted Convertible Notes", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxONE5MRW95TmJqRTB2bjhseTFCNzVkTEgtS2lLN3hwSXhwQWtPLTZtMmdxdmRRTjF1ODRFanpVOW9ZV3BFeFJ6d3MwNHpYaFh2Z2ZxNkdVQ3ZxdWhLRWR4MHRQSFZWUTdxX3hnNERLMnAxbVdHaDFRRkJMLTRjei1PYVFIZkdkb1BNOWlXNUNqcko4Q3BCVUNnTC1uZ2h6akdPSnhhY0FneDlrVmhGMjltSVJR?oc=5", "source_name": "TipRanks", "published_at": "2026-07-14T09:19:13+00:00", "published_display": "14 Jul 2026 09:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen stock holds steady as diagnostics demand shapes long term outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxQelQ5VFNlelhIMTJsZk10QUwxRE5sNFBOdEVJVVdSdHVFaS03NjJTXzE1NUZxNUJVUDB1a1k2VFlpM3IzYjFxX3dkVFg5UkxfRGt1Nl8takZ6Y0NSLWFHRzlIeFFwVnhHYlktNUIzN3JGZlZ6OUxwQlo3T1ZGUVJ4T2tXMnlzUlA1UVpoMFFpVlhxTlZhUTRUVWI2WjZRZHFIRHp4R0MyZE53SWI1Tk9KRmg0T3c2QkhnWEw3dDFXZXFCNTVpdDJJWVBHQQ?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-14T09:00:58+00:00", "published_display": "14 Jul 2026 09:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BCAL Diagnostics Issues 100,000 Unquoted Convertible Notes", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxPWVA2d0xhS2dBeEY0LXRhNlhBTnBFRnlTUVA5R3ViaWpET2NvZWNuSWpGdi1rMkpUd1otZ2dEaWZudnBpdVZQSldFSWFUbmZ4WmdfM0xxcVdIOVNvVEprZm54TGNxelhoYUd4U0VmMG80ZjJrbXh2X09UbHhELWRuN00zQ0g2WlhEZGxGR3NzclUybHJJTlk3dDVkejkydkk1LXFPV2d4TWtfREhyV1E?oc=5", "source_name": "TipRanks", "published_at": "2026-07-14T08:45:09+00:00", "published_display": "14 Jul 2026 08:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did BCAL Diagnostics Ltd (ASX: BDX) Jump 12.33%?", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxOTnZONFRfNnhHbGg0VHRCZ0xva0dkNERyV2dHNEdRYm5TcEVEcUNDdE1fTjVzTDl2OGRPWmMwbENGTW1rOGFSQ2lWa1djV2kwdGlmMXhUd1JLSnJlVV9VMUw3d0pKbWNWWHlTc2tGUzZpaUdmOS15bHRtSzh6SlEzN0N1bl9TUENHRkRobkVB?oc=5", "source_name": "Kalkine", "published_at": "2026-07-13T06:25:00+00:00", "published_display": "13 Jul 2026 06:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen stock holds steady as diagnostics demand supports long-term growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxQYXRxTGlQaFZybjJ5a2J0WHl5bXp5QTRPMS1vTG5XVUoyU3Z4ZlRiSnUtRTQ2TWF4dG9FSzkwYmRYcnhDZUFqXzVuSTdFVEg1eVU0TXBNS2k0V2xEdm9MR3lzNTlCMzN3UEpMNmppZTlfbEZRWGloRm84VjllY0dtTUNMM3pCZFdyVUlPaS1saXdOOU1OVzVDa29zRURQZXlsRVZ6M3pITWVVSmVyQXZpSXIwWGxyaWxQZ1VNRTgwRGo4RndMZEE2MERVZlQ?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-13T06:08:44+00:00", "published_display": "13 Jul 2026 06:08", "sentiment": "positive", "sentiment_pct": 66, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen stock reflects steady diagnostics demand as investors weigh long-term growth drivers", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOT0p5UGpYTGw0d1loeEdBbndGeFltLXVyMWdtWFl1eXYydnhXancxcnpWMUJvN3Y0RWxFTmljekw4b3BERndMUUduUW8xQUY3TktkRV9TOS1PcHJmaFNrV01pVWkzQzJJbG9fWjhUN0FDS2Vqa3JmenB2ellkUHZiMl9DRkJBbUNKcm85RndRd2tkU1dMLU5rRl9CNVZPQ1p6T1VkOF9OTEZoVDJKNi0xVDRjajNXVTA0eFVVY0RrWXQwS2M?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-12T12:19:06+00:00", "published_display": "12 Jul 2026 12:19", "sentiment": "positive", "sentiment_pct": 66, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Roche stock holds steady as pharma giant leans on diagnostics and oncology strength", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxPa0hsdjNPUWxBTFVtcXYyOUpSbnB0WnpoR1k5c1EyaFVPOXJmR0NROGpoazIwMC1FWFFiYmh4VGl5ZkZHbEFtNXNBalBIbTY5Q29aSXdNTkpiNEU4ZDdIZHJ2SjNoYjRqaHBLdUNSYTBieUhEdHBzc1V0UFQ3QkxPZ0s0d2pSWWhid3pOQW5uMUVHRmRpQmpCa0FkY2hrVHM4c2ViTFRWOWpLVkY2NWpBM0FuMkFDZWlUaG5ncWl4ckxNeENDMjhHWVpUSG8xUQ?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-11T08:31:21+00:00", "published_display": "11 Jul 2026 08:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Labcorp stock holds its business focus. Clinical diagnostics remain the core.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQTEN6RDNESkFmZDlqelJTb2V5b2txajhDRHJVd3RmR01BT0VyVjdvdllJMEZtNzRkQ0VyekhNU2Z4V0Q3S29SWXBtTndrSHpmcGQ3TzRyZW8wXzI1NzVoV1UtT1JpbDJJMmo2TXdBNy1EX2NOVlgzZ1lERmlyYThrSmJIcGVrQkVJa3lJLTFRSV9EUWhocDc5cWU1MjFEVGxJRWtCVE8yQkloZHVCTGV0SjVucktQSEJUSVJTZzdhUGFwVnVNNnA4Zg?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-08T09:51:39+00:00", "published_display": "08 Jul 2026 09:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen N.V. highlights molecular diagnostics growth as investors eye global health demand", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOQko3MXlYWXFwTHkxSnMxOV9tY1VOWVJqOFpMc2JTYS1LU191dDgzWUM4Rnp1MGNGSVBsSW50OGs4SU1maVVDcHZ1aUg3TVF6Y1hheUNlVjU4cHBqRWl3dk5lRHYtb01xSWRocm9HSFVObUFsd2RjeE5KRHVtWElaMzhvcDBwdW9pX1BzcTBuTXNwYmhzMmVsaWE5eFEwWDFoekxXQVo1Skw4aXJoS1YwQWpSMnZHQkJ4RG90YnVyZFVWa0J5?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-06T06:41:22+00:00", "published_display": "06 Jul 2026 06:41", "sentiment": "positive", "sentiment_pct": 66, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BCAL Diagnostics (ASX:BDX) Expands Diagnostics Strategy with New Investment", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQTGlwTVA1bVZRVk5OUVdabUg2dW1CZF9fRkpSMWJ0WU9NT3h2S0EzTl9DZ2Z5MzRDb2F0VHlCbTJGSThEakNlV3c3M2RhY1dMc0xpM1J6eTNrMkVOYzVLVnphTDNGR3doV0swdmpldi1iYVNiR25Dc0FCQm9TV2tKcXJlQ25VdXVGRnVnY1VHeTRVRlNQWUZjMXNJWnVZeDBWSVZESk1STy1RVXVNaEV2OA?oc=5", "source_name": "Kalkine", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BCAL Diagnostics Crosses 10% Threshold in Genetic Signatures with $1.39 Million Share Purchase", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxQOUgxdXZyOTh6dnF3Um54NkRHT0YtVVUzV1JzTDRsb3NyWnNDZUxTeU1fMV9yN28zRnJrVlJtNnQtQTJEYVpVTHMzcmhXa3hEbFphV3A2T0VHNzU5V3AyeVc3VzBSR28xb0JwWS10SFpiRkhtSkdVZDUwN2JhclZRN242RmlpRFFuNWUwbGRyVHhKMVdWWl81TkNUc01jZUZQaVBwb3IxSHRqbjdCajhNWjJfVWptNlhUR0FaWDdaaFVJXzBhNHEzS203ekNEQQ?oc=5", "source_name": "Kalkine", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BCAL Diagnostics Secures $4.9 Million Convertible Note Top-Up and $1.4 Million R&D Tax Offset to Fund FY2027 Cancer Detection Pipeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAJBVV95cUxPTGwyTE5SRUc4Q0JlSHJENXBBcllRaDdmblhzUnF6SFE3YUtya2NQSVBQaXVFT2RuOERZTDFpanFEZnFOQ2EtcGUwb0g1QlNtWlhUdVdacVVwNThHV1VUUGFmblp3WTdRXy01NU1nRFlsWDA5ZHRyaTU5VHFwTjJSOXhPZ1ZwZ2x1R2RYbXVRS1dZYl9LTU5fQU5lZ2s0SFAyUDY0Vk1zVlFHYl9LWUx6SmlveGd0Mk90SUpqT0Jmd3g0b0N5Rnd1MzZMc0NiQkRYZnVwMExfVkh5QS1oSkxvS1FuNTN6MndGNlctUnpQRXhtNnE3VDJFeVlEMk5LTlph?oc=5", "source_name": "Kalkine", "published_at": "2026-06-29T02:32:15+00:00", "published_display": "29 Jun 2026 02:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen N.V. updates earnings calendar, shares tracked against diagnostics peers", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOUTNqbEpUTW4xd3RUTE5nMEt0ZEJFT25xZVBoYjRYYk56b18xdkwyWFJncVR1cjMwa25pbUhudWk2Ukk5RlBqLU1fRXo5YmZXNlZQMG5ubnExM1o4YXZpSDE3enY4T0MtLTVIS1dnYUlVWTZMNW5HVkFKNVFFbFZRVnQ3Z0ZkNnJmN0NMRHVRZXJtQkw2b1RUazZSZW1yaTVCM0VVYU9RM1o3YWF4MHlZM2ppSWZnekVxUEN4Y01GaWRiUXVTMHE0bXRB?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-06-26T05:11:57+00:00", "published_display": "26 Jun 2026 05:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics Stock - Analyst targets, sector review and weekly recap", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxONXVEeDZuTjZDaXh0dnlqY0NPTENZX0c4cFBxSDV3UWh1NC1XMU9ialR4Wk5TbnlpRVpXU05EVENEYjAtcGpoZmR2TVhLandUM0tIS2V4Rmk0dDZJMk44bm9tbl9SRUwtcGNLOXBGOGp4WlNpeE1aY0ZwRDdEZzB2NDhhUXFCV0p1MFB2djBnaDdfREtqMmhHcTFFMHIwcy1qOURxR2c2QTQzTkNsczZqbklmb0h2WlE5OE51cUlZU0VyY2ZMeUpHVw?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-06-19T16:09:41+00:00", "published_display": "19 Jun 2026 16:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BCAL Diagnostics (ASX:BDX): The Breast Cancer Blood Test Story Investors Are Watching in 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxPSEtwanFJVHhVZUFjWUtacDUtVlFSQVVVeURvVjlkNjBYTmo4RG00UGV2SldqVkFoQ1hCekd2c1YxNHl4NjNiOTVxeVM1cHR1azZHQ0RhOG94SlQzbkt0bnlNT3MzU2ItTFZXSGdrcVVwbzlsOFBVRmZYdGlselhDdUUtQmdXeHhKRnZ3bWFUd3FXSW9ubW9Za3FWX3hQbDl1Mk1FelJBam0xWUFFNEJ0d0tHT0l0SEhnVmc5bE9lcTRKNm8xZmhr?oc=5", "source_name": "Kalkine", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BCAL Diagnostics develops breast cancer test with 91% sensitivity", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNSnpJZ1FiX1VuV1Awem9uWDk5QjR5WVpqbDBFXzJsY2x1SHpWcFQtQ0pmNmdfdWdDQmpQb1A4MEhjN3FNTi1XeHdIbFNVdXBvc3FmS3FpUUs2T3RlcVFrQkhMZ3Z6OWNTbkJUNzF4VXpvaWptLVRDYXhzM1ZmN19BMXk4dk9XZk41RkVIYmRIYjhyV01OMUk4emhTdkFhUmRCUmc?oc=5", "source_name": "grafa.com", "published_at": "2026-06-18T05:33:37+00:00", "published_display": "18 Jun 2026 05:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BCAL Diagnostics Develops Blood Test for Breast Cancer Recurrence Monitoring", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQQ3JfbWxfUlFsX2VQbjZnV0F5ZXFkTVpYR3F6NXZuaWlxbUhqeTJfTktkV0I5NTRvdDdhUFR5S2REa1dEMGZyWUtGVkZhUld6ZWhNNWhENzZqWEFSVlpIQzhiekZ2UXZaenJqbUwzTlpyTnlGcGVLTGIxZEpYdm5xNXhaSk1nN29SVi01ckRTQXg4eWROWWZ1ZFM1cjRaNGFyNWlQZkRJa3ZKQjdDZnc?oc=5", "source_name": "smallcaps.com.au", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BCAL (ASX:BDX) Diagnostics Expands National Access to Early Cancer Detection Blood Tests", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPNkhwRzhLaF9GMnNUMHg3b0FzVFo3WGZTTG1DQzkzbnZPdlN3d0QyVmFpR0JteVIzcmZqNVV3RU8xRldrNEJzdHBYUGFrV2pIS2VBeEpDbTRLY1I3eEFGMHVtblc5WlRWSHNWakR3WDVtd3BoOTIwZFRMaDM1bDM2VWpySS0wSDNvZDVMMFJwVUVGdTdPeVRkeVBkbFVycGlQaXl3TS1iWDBua3VOdVB0VUZfLS1iQ1JOanExTzB1ZnJKdw?oc=5", "source_name": "Kalkine", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BCAL Diagnostics (ASX:BDX) Shares Rally on Expansion of National Cancer Test Access", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxNVUFxN3dRaHVNSl9NbDQ5TFE4TTN3SDhQXzlKUUR5ek55TFBxbS1reF9KLXQ3SGZMbHZEZlFsNndaUlBCbVNDQURjZVZBT1MwT3dHU1dlQllCRDZxY2NoVlRvNkdFNkFxRjhvWFZjd3hPLWk2aWsxR3ZocTRUTkZ4UmZlbUJXbDF2Q1VjVVZZWnNLZ2d0YmVPb1FodlhNbUctM25XYzljSnpENmhOS3VWVnN1b1JsSjlfOTRN?oc=5", "source_name": "Kalkine", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BCAL Diagnostics Accelerates Avantect Rollout via Sonic Healthcare and Healius Partnerships", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxPUUExM0docEYxOHFDLTFEVUtUSUVvdHFFVm5zS0tIamJmWGtzUzBFeE5JLWdGbHVqZWlpUXRMZnQ1enNLRWxCY29BTVJSWFJqUU5hcHF4aGRvMmdYYllUUEluZmNLdGFZdXI3eHdpT3Y2TDZ0ZkE2dzlOVm9iMjV6d1RSaExtSkltMnJsS1NNZ3VZODR4ajd6VnNYOWFVa09nM09IWGZnTjBocFBmTHpJa1R1Q2wzWktvYXptTHZGeUJKejJkc2ZXdGFNTWgxSE0?oc=5", "source_name": "smallcaps.com.au", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bcal Diagnostics (ASX:BDX)-What the Latest Share Price Drop Means for Investors?", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxOR25fdEdTX21YeDU5N1lHRWw1MkZTcWFuWmJFTjF0UnNYMktVRlFBX1U3NldHUHFBMDd6bFRyNWd4WWxzN0t1d25ERFFtbGdwbTFSa2tYQ1pYU2dXTkl1ZnROc0RJaGU2X2x0VlBVNFNJWVJuMWUyZW5JYTU2enh5eDhQZUVTYWFRWU9Lc2dNLVA1UklYMHZUNGJ0c0hUVG5iUjg1dFhwaDdKZnJpTHFHa0xxbDlmQQ?oc=5", "source_name": "Kalkine", "published_at": "2026-03-13T07:00:00+00:00", "published_display": "13 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BCAL Diagnostics (ASX: BDX): Interview with Executive Chair Jayne Shaw", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE1ZTjc3MThPSHNuT0thcjNQdEp0WlBmMUVsdnhXem5NOE44RlB6UDNvT1pLZHJXM2hjZmNzZkZqM09Tek0xazM0eGFQQnBJNThKcHl2MjQ2V2JfTmhaV1VYQVNnZ2p0SmtsakZFbFVn?oc=5", "source_name": "Stocks Down Under", "published_at": "2026-03-02T22:34:58+00:00", "published_display": "02 Mar 2026 22:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BCAL Diagnostics (ASX:BDX) Secures Exclusive Licence for Cancer Blood Tests in Australia and New Zealand", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxNMmNMSTJBZUNhTEVJQ09yMnZVTkFYTVhsenJBNDROTnNhdTdwVVZTSzFWdjNFZmc5cC15RVlTck9UcWEwZUpWWHhwTmNUQ21keHdNOGNMSFhBaWJMVjFxSzBJZWluRVFQTVg2aGowcnk1Yl9Ld2VPaEQyeVZka0ptcDJZN2xnZTZEeVd3ZU5ZMGdkb0lwTzRvZGlUNjR2b05FSlY4a2lWLWRsUWdhY2F0UWFwQk9pSktNZWE1Tm1HSlBKMDZtN0trZF8xdVZNWm9idzBNem54aw?oc=5", "source_name": "Kalkine", "published_at": "2025-09-18T07:00:00+00:00", "published_display": "18 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BCAL Diagnostics Launches BREASTEST plus - Generating First Revenues", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOX2JXMEFzdFJNQ2RIMzk5SUx5LWFSNU9hRHhSMFZrMEFZZmxfdG1kbFZMa1IwR2J4NTZYYnlZTGhoX3ByaXRRQmxXdU9vMktVbkZ1SUVqRTVzMWNjOC15dWw2b3c0ZVl4enE1bkFaQzN0WGwzUFljTk9wOFR3UlB5S0IyMlhVQXN1V0ZDLTlwYjFRS1VDcWtWOQ?oc=5", "source_name": "Investing News Network", "published_at": "2025-03-23T07:00:00+00:00", "published_display": "23 Mar 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BCAL Diagnostics Limited (ASX: BDX) - Share Price", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxPVWVZelQ4Sjl2UnhtNTNjaDlWZjZ0NFdQWTN5d2w3Vl9aekpZSXFxNDdzbk15aFBySFBOMkFXQlpYQnhUSXU1THp0bHpZN0ZFQjRLY1hsZHU5VThJbFp4Z1NaaDJreXFMWGZlTjhIc2ZwRkwzY1FnOFpfaXg3bWVzZ3ZDaS1vYjBLN2Y0VmMyM3FWY19R?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2021-07-22T15:38:26+00:00", "published_display": "22 Jul 2021 15:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "by_tier": {"direct": [{"title": "BCAL Diagnostics Issues 1 Million Unquoted Convertible Notes", "summary": "", "url": "https://news.google.com/rss/articles/CBMisgFBVV95cUxONE5MRW95TmJqRTB2bjhseTFCNzVkTEgtS2lLN3hwSXhwQWtPLTZtMmdxdmRRTjF1ODRFanpVOW9ZV3BFeFJ6d3MwNHpYaFh2Z2ZxNkdVQ3ZxdWhLRWR4MHRQSFZWUTdxX3hnNERLMnAxbVdHaDFRRkJMLTRjei1PYVFIZkdkb1BNOWlXNUNqcko4Q3BCVUNnTC1uZ2h6akdPSnhhY0FneDlrVmhGMjltSVJR?oc=5", "source_name": "TipRanks", "published_at": "2026-07-14T09:19:13+00:00", "published_display": "14 Jul 2026 09:19", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen stock holds steady as diagnostics demand shapes long term outlook", "summary": "", "url": "https://news.google.com/rss/articles/CBMiywFBVV95cUxQelQ5VFNlelhIMTJsZk10QUwxRE5sNFBOdEVJVVdSdHVFaS03NjJTXzE1NUZxNUJVUDB1a1k2VFlpM3IzYjFxX3dkVFg5UkxfRGt1Nl8takZ6Y0NSLWFHRzlIeFFwVnhHYlktNUIzN3JGZlZ6OUxwQlo3T1ZGUVJ4T2tXMnlzUlA1UVpoMFFpVlhxTlZhUTRUVWI2WjZRZHFIRHp4R0MyZE53SWI1Tk9KRmg0T3c2QkhnWEw3dDFXZXFCNTVpdDJJWVBHQQ?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-14T09:00:58+00:00", "published_display": "14 Jul 2026 09:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "guidance", "event_label": "Guidance", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BCAL Diagnostics Issues 100,000 Unquoted Convertible Notes", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxPWVA2d0xhS2dBeEY0LXRhNlhBTnBFRnlTUVA5R3ViaWpET2NvZWNuSWpGdi1rMkpUd1otZ2dEaWZudnBpdVZQSldFSWFUbmZ4WmdfM0xxcVdIOVNvVEprZm54TGNxelhoYUd4U0VmMG80ZjJrbXh2X09UbHhELWRuN00zQ0g2WlhEZGxGR3NzclUybHJJTlk3dDVkejkydkk1LXFPV2d4TWtfREhyV1E?oc=5", "source_name": "TipRanks", "published_at": "2026-07-14T08:45:09+00:00", "published_display": "14 Jul 2026 08:45", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Why Did BCAL Diagnostics Ltd (ASX: BDX) Jump 12.33%?", "summary": "", "url": "https://news.google.com/rss/articles/CBMijgFBVV95cUxOTnZONFRfNnhHbGg0VHRCZ0xva0dkNERyV2dHNEdRYm5TcEVEcUNDdE1fTjVzTDl2OGRPWmMwbENGTW1rOGFSQ2lWa1djV2kwdGlmMXhUd1JLSnJlVV9VMUw3d0pKbWNWWHlTc2tGUzZpaUdmOS15bHRtSzh6SlEzN0N1bl9TUENHRkRobkVB?oc=5", "source_name": "Kalkine", "published_at": "2026-07-13T06:25:00+00:00", "published_display": "13 Jul 2026 06:25", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen stock holds steady as diagnostics demand supports long-term growth", "summary": "", "url": "https://news.google.com/rss/articles/CBMizAFBVV95cUxQYXRxTGlQaFZybjJ5a2J0WHl5bXp5QTRPMS1vTG5XVUoyU3Z4ZlRiSnUtRTQ2TWF4dG9FSzkwYmRYcnhDZUFqXzVuSTdFVEg1eVU0TXBNS2k0V2xEdm9MR3lzNTlCMzN3UEpMNmppZTlfbEZRWGloRm84VjllY0dtTUNMM3pCZFdyVUlPaS1saXdOOU1OVzVDa29zRURQZXlsRVZ6M3pITWVVSmVyQXZpSXIwWGxyaWxQZ1VNRTgwRGo4RndMZEE2MERVZlQ?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-13T06:08:44+00:00", "published_display": "13 Jul 2026 06:08", "sentiment": "positive", "sentiment_pct": 66, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen stock reflects steady diagnostics demand as investors weigh long-term growth drivers", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwwFBVV95cUxOT0p5UGpYTGw0d1loeEdBbndGeFltLXVyMWdtWFl1eXYydnhXancxcnpWMUJvN3Y0RWxFTmljekw4b3BERndMUUduUW8xQUY3TktkRV9TOS1PcHJmaFNrV01pVWkzQzJJbG9fWjhUN0FDS2Vqa3JmenB2ellkUHZiMl9DRkJBbUNKcm85RndRd2tkU1dMLU5rRl9CNVZPQ1p6T1VkOF9OTEZoVDJKNi0xVDRjajNXVTA0eFVVY0RrWXQwS2M?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-12T12:19:06+00:00", "published_display": "12 Jul 2026 12:19", "sentiment": "positive", "sentiment_pct": 66, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Roche stock holds steady as pharma giant leans on diagnostics and oncology strength", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxPa0hsdjNPUWxBTFVtcXYyOUpSbnB0WnpoR1k5c1EyaFVPOXJmR0NROGpoazIwMC1FWFFiYmh4VGl5ZkZHbEFtNXNBalBIbTY5Q29aSXdNTkpiNEU4ZDdIZHJ2SjNoYjRqaHBLdUNSYTBieUhEdHBzc1V0UFQ3QkxPZ0s0d2pSWWhid3pOQW5uMUVHRmRpQmpCa0FkY2hrVHM4c2ViTFRWOWpLVkY2NWpBM0FuMkFDZWlUaG5ncWl4ckxNeENDMjhHWVpUSG8xUQ?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-11T08:31:21+00:00", "published_display": "11 Jul 2026 08:31", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Labcorp stock holds its business focus. Clinical diagnostics remain the core.", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxQTEN6RDNESkFmZDlqelJTb2V5b2txajhDRHJVd3RmR01BT0VyVjdvdllJMEZtNzRkQ0VyekhNU2Z4V0Q3S29SWXBtTndrSHpmcGQ3TzRyZW8wXzI1NzVoV1UtT1JpbDJJMmo2TXdBNy1EX2NOVlgzZ1lERmlyYThrSmJIcGVrQkVJa3lJLTFRSV9EUWhocDc5cWU1MjFEVGxJRWtCVE8yQkloZHVCTGV0SjVucktQSEJUSVJTZzdhUGFwVnVNNnA4Zg?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-08T09:51:39+00:00", "published_display": "08 Jul 2026 09:51", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen N.V. highlights molecular diagnostics growth as investors eye global health demand", "summary": "", "url": "https://news.google.com/rss/articles/CBMixAFBVV95cUxOQko3MXlYWXFwTHkxSnMxOV9tY1VOWVJqOFpMc2JTYS1LU191dDgzWUM4Rnp1MGNGSVBsSW50OGs4SU1maVVDcHZ1aUg3TVF6Y1hheUNlVjU4cHBqRWl3dk5lRHYtb01xSWRocm9HSFVObUFsd2RjeE5KRHVtWElaMzhvcDBwdW9pX1BzcTBuTXNwYmhzMmVsaWE5eFEwWDFoekxXQVo1Skw4aXJoS1YwQWpSMnZHQkJ4RG90YnVyZFVWa0J5?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-07-06T06:41:22+00:00", "published_display": "06 Jul 2026 06:41", "sentiment": "positive", "sentiment_pct": 66, "event_type": "macro", "event_label": "Macro sensitivity", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BCAL Diagnostics (ASX:BDX) Expands Diagnostics Strategy with New Investment", "summary": "", "url": "https://news.google.com/rss/articles/CBMisAFBVV95cUxQTGlwTVA1bVZRVk5OUVdabUg2dW1CZF9fRkpSMWJ0WU9NT3h2S0EzTl9DZ2Z5MzRDb2F0VHlCbTJGSThEakNlV3c3M2RhY1dMc0xpM1J6eTNrMkVOYzVLVnphTDNGR3doV0swdmpldi1iYVNiR25Dc0FCQm9TV2tKcXJlQ25VdXVGRnVnY1VHeTRVRlNQWUZjMXNJWnVZeDBWSVZESk1STy1RVXVNaEV2OA?oc=5", "source_name": "Kalkine", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BCAL Diagnostics Crosses 10% Threshold in Genetic Signatures with $1.39 Million Share Purchase", "summary": "", "url": "https://news.google.com/rss/articles/CBMizgFBVV95cUxQOUgxdXZyOTh6dnF3Um54NkRHT0YtVVUzV1JzTDRsb3NyWnNDZUxTeU1fMV9yN28zRnJrVlJtNnQtQTJEYVpVTHMzcmhXa3hEbFphV3A2T0VHNzU5V3AyeVc3VzBSR28xb0JwWS10SFpiRkhtSkdVZDUwN2JhclZRN242RmlpRFFuNWUwbGRyVHhKMVdWWl81TkNUc01jZUZQaVBwb3IxSHRqbjdCajhNWjJfVWptNlhUR0FaWDdaaFVJXzBhNHEzS203ekNEQQ?oc=5", "source_name": "Kalkine", "published_at": "2026-07-02T07:00:00+00:00", "published_display": "02 Jul 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BCAL Diagnostics Secures $4.9 Million Convertible Note Top-Up and $1.4 Million R&D Tax Offset to Fund FY2027 Cancer Detection Pipeline", "summary": "", "url": "https://news.google.com/rss/articles/CBMigAJBVV95cUxPTGwyTE5SRUc4Q0JlSHJENXBBcllRaDdmblhzUnF6SFE3YUtya2NQSVBQaXVFT2RuOERZTDFpanFEZnFOQ2EtcGUwb0g1QlNtWlhUdVdacVVwNThHV1VUUGFmblp3WTdRXy01NU1nRFlsWDA5ZHRyaTU5VHFwTjJSOXhPZ1ZwZ2x1R2RYbXVRS1dZYl9LTU5fQU5lZ2s0SFAyUDY0Vk1zVlFHYl9LWUx6SmlveGd0Mk90SUpqT0Jmd3g0b0N5Rnd1MzZMc0NiQkRYZnVwMExfVkh5QS1oSkxvS1FuNTN6MndGNlctUnpQRXhtNnE3VDJFeVlEMk5LTlph?oc=5", "source_name": "Kalkine", "published_at": "2026-06-29T02:32:15+00:00", "published_display": "29 Jun 2026 02:32", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Qiagen N.V. updates earnings calendar, shares tracked against diagnostics peers", "summary": "", "url": "https://news.google.com/rss/articles/CBMiygFBVV95cUxOUTNqbEpUTW4xd3RUTE5nMEt0ZEJFT25xZVBoYjRYYk56b18xdkwyWFJncVR1cjMwa25pbUhudWk2Ukk5RlBqLU1fRXo5YmZXNlZQMG5ubnExM1o4YXZpSDE3enY4T0MtLTVIS1dnYUlVWTZMNW5HVkFKNVFFbFZRVnQ3Z0ZkNnJmN0NMRHVRZXJtQkw2b1RUazZSZW1yaTVCM0VVYU9RM1o3YWF4MHlZM2ppSWZnekVxUEN4Y01GaWRiUXVTMHE0bXRB?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-06-26T05:11:57+00:00", "published_display": "26 Jun 2026 05:11", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "earnings", "event_label": "Earnings", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Quest Diagnostics Stock - Analyst targets, sector review and weekly recap", "summary": "", "url": "https://news.google.com/rss/articles/CBMiyAFBVV95cUxONXVEeDZuTjZDaXh0dnlqY0NPTENZX0c4cFBxSDV3UWh1NC1XMU9ialR4Wk5TbnlpRVpXU05EVENEYjAtcGpoZmR2TVhLandUM0tIS2V4Rmk0dDZJMk44bm9tbl9SRUwtcGNLOXBGOGp4WlNpeE1aY0ZwRDdEZzB2NDhhUXFCV0p1MFB2djBnaDdfREtqMmhHcTFFMHIwcy1qOURxR2c2QTQzTkNsczZqbklmb0h2WlE5OE51cUlZU0VyY2ZMeUpHVw?oc=5", "source_name": "ad-hoc-news.de", "published_at": "2026-06-19T16:09:41+00:00", "published_display": "19 Jun 2026 16:09", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "analyst", "event_label": "Analyst action", "event_confidence": 53, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BCAL Diagnostics (ASX:BDX): The Breast Cancer Blood Test Story Investors Are Watching in 2026", "summary": "", "url": "https://news.google.com/rss/articles/CBMixwFBVV95cUxPSEtwanFJVHhVZUFjWUtacDUtVlFSQVVVeURvVjlkNjBYTmo4RG00UGV2SldqVkFoQ1hCekd2c1YxNHl4NjNiOTVxeVM1cHR1azZHQ0RhOG94SlQzbkt0bnlNT3MzU2ItTFZXSGdrcVVwbzlsOFBVRmZYdGlselhDdUUtQmdXeHhKRnZ3bWFUd3FXSW9ubW9Za3FWX3hQbDl1Mk1FelJBam0xWUFFNEJ0d0tHT0l0SEhnVmc5bE9lcTRKNm8xZmhr?oc=5", "source_name": "Kalkine", "published_at": "2026-06-18T07:00:00+00:00", "published_display": "18 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BCAL Diagnostics develops breast cancer test with 91% sensitivity", "summary": "", "url": "https://news.google.com/rss/articles/CBMiogFBVV95cUxNSnpJZ1FiX1VuV1Awem9uWDk5QjR5WVpqbDBFXzJsY2x1SHpWcFQtQ0pmNmdfdWdDQmpQb1A4MEhjN3FNTi1XeHdIbFNVdXBvc3FmS3FpUUs2T3RlcVFrQkhMZ3Z6OWNTbkJUNzF4VXpvaWptLVRDYXhzM1ZmN19BMXk4dk9XZk41RkVIYmRIYjhyV01OMUk4emhTdkFhUmRCUmc?oc=5", "source_name": "grafa.com", "published_at": "2026-06-18T05:33:37+00:00", "published_display": "18 Jun 2026 05:33", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BCAL Diagnostics Develops Blood Test for Breast Cancer Recurrence Monitoring", "summary": "", "url": "https://news.google.com/rss/articles/CBMirgFBVV95cUxQQ3JfbWxfUlFsX2VQbjZnV0F5ZXFkTVpYR3F6NXZuaWlxbUhqeTJfTktkV0I5NTRvdDdhUFR5S2REa1dEMGZyWUtGVkZhUld6ZWhNNWhENzZqWEFSVlpIQzhiekZ2UXZaenJqbUwzTlpyTnlGcGVLTGIxZEpYdm5xNXhaSk1nN29SVi01ckRTQXg4eWROWWZ1ZFM1cjRaNGFyNWlQZkRJa3ZKQjdDZnc?oc=5", "source_name": "smallcaps.com.au", "published_at": "2026-06-17T07:00:00+00:00", "published_display": "17 Jun 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BCAL (ASX:BDX) Diagnostics Expands National Access to Early Cancer Detection Blood Tests", "summary": "", "url": "https://news.google.com/rss/articles/CBMiwgFBVV95cUxPNkhwRzhLaF9GMnNUMHg3b0FzVFo3WGZTTG1DQzkzbnZPdlN3d0QyVmFpR0JteVIzcmZqNVV3RU8xRldrNEJzdHBYUGFrV2pIS2VBeEpDbTRLY1I3eEFGMHVtblc5WlRWSHNWakR3WDVtd3BoOTIwZFRMaDM1bDM2VWpySS0wSDNvZDVMMFJwVUVGdTdPeVRkeVBkbFVycGlQaXl3TS1iWDBua3VOdVB0VUZfLS1iQ1JOanExTzB1ZnJKdw?oc=5", "source_name": "Kalkine", "published_at": "2026-05-20T07:00:00+00:00", "published_display": "20 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BCAL Diagnostics (ASX:BDX) Shares Rally on Expansion of National Cancer Test Access", "summary": "", "url": "https://news.google.com/rss/articles/CBMiuwFBVV95cUxNVUFxN3dRaHVNSl9NbDQ5TFE4TTN3SDhQXzlKUUR5ek55TFBxbS1reF9KLXQ3SGZMbHZEZlFsNndaUlBCbVNDQURjZVZBT1MwT3dHU1dlQllCRDZxY2NoVlRvNkdFNkFxRjhvWFZjd3hPLWk2aWsxR3ZocTRUTkZ4UmZlbUJXbDF2Q1VjVVZZWnNLZ2d0YmVPb1FodlhNbUctM25XYzljSnpENmhOS3VWVnN1b1JsSjlfOTRN?oc=5", "source_name": "Kalkine", "published_at": "2026-05-19T07:00:00+00:00", "published_display": "19 May 2026 07:00", "sentiment": "positive", "sentiment_pct": 66, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BCAL Diagnostics Accelerates Avantect Rollout via Sonic Healthcare and Healius Partnerships", "summary": "", "url": "https://news.google.com/rss/articles/CBMizwFBVV95cUxPUUExM0docEYxOHFDLTFEVUtUSUVvdHFFVm5zS0tIamJmWGtzUzBFeE5JLWdGbHVqZWlpUXRMZnQ1enNLRWxCY29BTVJSWFJqUU5hcHF4aGRvMmdYYllUUEluZmNLdGFZdXI3eHdpT3Y2TDZ0ZkE2dzlOVm9iMjV6d1RSaExtSkltMnJsS1NNZ3VZODR4ajd6VnNYOWFVa09nM09IWGZnTjBocFBmTHpJa1R1Q2wzWktvYXptTHZGeUJKejJkc2ZXdGFNTWgxSE0?oc=5", "source_name": "smallcaps.com.au", "published_at": "2026-03-25T07:00:00+00:00", "published_display": "25 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "Bcal Diagnostics (ASX:BDX)-What the Latest Share Price Drop Means for Investors?", "summary": "", "url": "https://news.google.com/rss/articles/CBMitgFBVV95cUxOR25fdEdTX21YeDU5N1lHRWw1MkZTcWFuWmJFTjF0UnNYMktVRlFBX1U3NldHUHFBMDd6bFRyNWd4WWxzN0t1d25ERFFtbGdwbTFSa2tYQ1pYU2dXTkl1ZnROc0RJaGU2X2x0VlBVNFNJWVJuMWUyZW5JYTU2enh5eDhQZUVTYWFRWU9Lc2dNLVA1UklYMHZUNGJ0c0hUVG5iUjg1dFhwaDdKZnJpTHFHa0xxbDlmQQ?oc=5", "source_name": "Kalkine", "published_at": "2026-03-13T07:00:00+00:00", "published_display": "13 Mar 2026 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BCAL Diagnostics (ASX: BDX): Interview with Executive Chair Jayne Shaw", "summary": "", "url": "https://news.google.com/rss/articles/CBMibkFVX3lxTE1ZTjc3MThPSHNuT0thcjNQdEp0WlBmMUVsdnhXem5NOE44RlB6UDNvT1pLZHJXM2hjZmNzZkZqM09Tek0xazM0eGFQQnBJNThKcHl2MjQ2V2JfTmhaV1VYQVNnZ2p0SmtsakZFbFVn?oc=5", "source_name": "Stocks Down Under", "published_at": "2026-03-02T22:34:58+00:00", "published_display": "02 Mar 2026 22:34", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BCAL Diagnostics (ASX:BDX) Secures Exclusive Licence for Cancer Blood Tests in Australia and New Zealand", "summary": "", "url": "https://news.google.com/rss/articles/CBMi1wFBVV95cUxNMmNMSTJBZUNhTEVJQ09yMnZVTkFYTVhsenJBNDROTnNhdTdwVVZTSzFWdjNFZmc5cC15RVlTck9UcWEwZUpWWHhwTmNUQ21keHdNOGNMSFhBaWJMVjFxSzBJZWluRVFQTVg2aGowcnk1Yl9Ld2VPaEQyeVZka0ptcDJZN2xnZTZEeVd3ZU5ZMGdkb0lwTzRvZGlUNjR2b05FSlY4a2lWLWRsUWdhY2F0UWFwQk9pSktNZWE1Tm1HSlBKMDZtN0trZF8xdVZNWm9idzBNem54aw?oc=5", "source_name": "Kalkine", "published_at": "2025-09-18T07:00:00+00:00", "published_display": "18 Sep 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BCAL Diagnostics Launches BREASTEST plus - Generating First Revenues", "summary": "", "url": "https://news.google.com/rss/articles/CBMimAFBVV95cUxOX2JXMEFzdFJNQ2RIMzk5SUx5LWFSNU9hRHhSMFZrMEFZZmxfdG1kbFZMa1IwR2J4NTZYYnlZTGhoX3ByaXRRQmxXdU9vMktVbkZ1SUVqRTVzMWNjOC15dWw2b3c0ZVl4enE1bkFaQzN0WGwzUFljTk9wOFR3UlB5S0IyMlhVQXN1V0ZDLTlwYjFRS1VDcWtWOQ?oc=5", "source_name": "Investing News Network", "published_at": "2025-03-23T07:00:00+00:00", "published_display": "23 Mar 2025 07:00", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}, {"title": "BCAL Diagnostics Limited (ASX: BDX) - Share Price", "summary": "", "url": "https://news.google.com/rss/articles/CBMilAFBVV95cUxPVWVZelQ4Sjl2UnhtNTNjaDlWZjZ0NFdQWTN5d2w3Vl9aekpZSXFxNDdzbk15aFBySFBOMkFXQlpYQnhUSXU1THp0bHpZN0ZFQjRLY1hsZHU5VThJbFp4Z1NaaDJreXFMWGZlTjhIc2ZwRkwzY1FnOFpfaXg3bWVzZ3ZDaS1vYjBLN2Y0VmMyM3FWY19R?oc=5", "source_name": "intelligentinvestor.com.au", "published_at": "2021-07-22T15:38:26+00:00", "published_display": "22 Jul 2021 15:38", "sentiment": "neutral", "sentiment_pct": 50, "event_type": "general", "event_label": "Market update", "event_confidence": 35, "tier": "direct", "tier_label": "Direct company coverage"}], "industry": [], "sector": []}, "total_fetched": 88, "total_relevant": 25, "sentiment_summary": {"positive": 6, "negative": 0, "neutral": 19, "score": 54, "total": 25, "label": "Balanced news tone", "tone": "neutral"}, "classifier": {"primary_event": "general", "primary_label": "Market update", "confidence": 87, "events": [{"event": "general", "label": "Market update", "weight": 10.45, "count": 19}, {"event": "macro", "label": "Macro sensitivity", "weight": 1.65, "count": 3}, {"event": "guidance", "label": "Guidance", "weight": 0.55, "count": 1}, {"event": "earnings", "label": "Earnings", "weight": 0.55, "count": 1}, {"event": "analyst", "label": "Analyst action", "weight": 0.55, "count": 1}], "positive_events": 6, "negative_events": 0}, "market_context": {"has_market_context": true, "latest_close": 0.07, "latest_week": "2026-07-10", "one_week_move": -2.7, "four_week_move": 4.3, "twelve_week_move": -18.9, "trend_signal": "0", "trend_label": "Trend inactive", "trend_tone": "negative", "market_dynamics": -0.498517, "market_dynamics_buy_signal": false, "relative_strength": -17.220401, "fair_value_gap": -25.1, "fair_value_label": "Below fair value", "fair_value_tone": "positive", "expectation_direction": "negative", "expectation_probability": 42.9733, "reaction_label": "Price reacting lower", "reaction_tone": "negative", "market_sentence": "-2.7% over one week, +4.3% over four weeks, trend inactive, and below fair value."}, "interpretation": {"label": "Balanced read", "tone": "neutral", "classification": "balanced", "summary": "News tone and price action are not far from neutral.", "confidence": 65, "badges": ["Value support"], "opportunities": ["Price is below fair value while news tone is not negative."], "risks": [], "event_label": "Market update", "sentiment_word": "balanced"}, "charts": {"sources": [{"label": "Kalkine", "count": 9}, {"label": "ad-hoc-news.de", "count": 8}, {"label": "TipRanks", "count": 2}, {"label": "smallcaps.com.au", "count": 2}, {"label": "grafa.com", "count": 1}, {"label": "Stocks Down Under", "count": 1}, {"label": "Investing News Network", "count": 1}, {"label": "intelligentinvestor.com.au", "count": 1}], "tiers": [{"label": "Direct company coverage", "count": 25}, {"label": "Industry context", "count": 0}, {"label": "Sector context", "count": 0}], "events": [{"label": "Market update", "count": 19}, {"label": "Macro sensitivity", "count": 3}, {"label": "Guidance", "count": 1}, {"label": "Earnings", "count": 1}, {"label": "Analyst action", "count": 1}]}, "insights": [{"label": "Weighted tone", "value": "54/100", "tone": "neutral", "text": "Balanced news tone"}, {"label": "Market reaction", "value": "Balanced read", "tone": "neutral", "text": "News tone and price action are not far from neutral."}, {"label": "Primary event", "value": "Market update", "tone": "neutral", "text": "87/100 classification confidence."}, {"label": "Company focus", "value": "25", "tone": "positive", "text": "directly relevant articles"}, {"label": "Source quality", "value": "0", "tone": "neutral", "text": "high-authority source matches"}, {"label": "Trend context", "value": "Trend inactive", "tone": "negative", "text": "-2.7% over one week, +4.3% over four weeks, trend inactive, and below fair value."}, {"label": "Latest direct headline", "value": "Neutral", "tone": "neutral", "text": "BCAL Diagnostics Issues 1 Million Unquoted Convertible Notes"}], "updated_at": "2026-07-16T22:50:27.762895+00:00", "disclaimer": "Educational market research only. Not financial, investment, trading, tax, or legal advice."}